MTR4 drives liver tumorigenesis by promoting cancer metabolic switch through alternative splicing
Aberrant alternative splicing has been shown to contribute to the tumorigenic processes. Here, the authors show that MTR4 is overexpressed in hepatocellular carcinoma and has a role in tumorigenesis through the modulation of the splicing of glycolytic genes PKM2 and GLUT1.
Guardado en:
Autores principales: | Lili Yu, Jinchul Kim, Lei Jiang, Bingbing Feng, Yue Ying, Kai-yuan Ji, Qingshuang Tang, Wancheng Chen, Taoyi Mai, Wenlong Dou, Jianlong Zhou, Le-yang Xiang, Yang-fan He, Dinghua Yang, Qingjiao Li, Xuemei Fu, Yang Xu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d6f7056973d7420fa80b0b12ab8c2f6e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Identification of prognostic alternative splicing events in sarcoma
por: Hongshuai Li, et al.
Publicado: (2021) -
Alternative splicing regulates distinct subcellular localization of Epithelial splicing regulatory protein 1 (Esrp1) isoforms
por: Yueqin Yang, et al.
Publicado: (2017) -
Alternative splicing level related to intron size and organism complexity
por: Pengcheng Yang, et al.
Publicado: (2021) -
Alternative splicing acts as an independent prognosticator in ovarian carcinoma
por: Yan Ouyang, et al.
Publicado: (2021) -
Alternative Splicing in Apicomplexan Parasites
por: Lee M. Yeoh, et al.
Publicado: (2019)